GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Revenue | 942.80K | 1.05M | 2.94M | 1.28M | 1.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 942.80K | 1.05M | 2.94M | 1.28M | 1.19M |
| Cost of Revenue | 514.70K | 232.90K | 579.80K | 752.50K | 1.08M |
| Gross Profit | 428.00K | 815.00K | 2.37M | 524.50K | 105.00K |
| SG&A Expenses | 933.30K | 1.25M | 930.40K | 1.18M | 1.19M |
| Depreciation & Amortization | 19.10K | 19.60K | 20.50K | 68.20K | 79.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.81M | 1.94M | 1.95M | 2.58M | 2.75M |
| Operating Income | -862.20K | -895.00K | 993.60K | -1.30M | -1.56M |
| Income Before Tax | -862.20K | -795.00K | 893.60K | -1.30M | -1.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -862.20K | -795.00K | 893.60K | -1.30M | -1.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -862.20K | -795.00K | 893.60K | -1.30M | -1.56M |
| EBIT | -862.20K | -895.00K | 993.60K | -1.30M | -1.56M |
| EBITDA | -843.10K | -875.50K | 1.01M | -1.24M | -1.48M |
| EPS Basic | -0.15 | -0.14 | 0.16 | -0.23 | -0.27 |
| Normalized Basic EPS | -0.09 | -0.10 | 0.11 | -0.14 | -0.17 |
| EPS Diluted | -0.15 | -0.14 | 0.13 | -0.23 | -0.27 |
| Normalized Diluted EPS | -0.09 | -0.10 | 0.09 | -0.14 | -0.17 |
| Average Basic Shares Outstanding | 5.75M | 5.75M | 5.75M | 5.75M | 5.75M |
| Average Diluted Shares Outstanding | 5.75M | 5.75M | 6.95M | 5.75M | 5.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |